NCT06759493 Validation and Simplification of the Retinol Isotope Dilution Technique in Burkinabe Schoolchildren
| NCT ID | NCT06759493 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut de Recherche en Sciences de la Sante, Burkina Faso |
| Condition | Vitamin A Deficiency |
| Study Type | OBSERVATIONAL |
| Enrollment | 158 participants |
| Start Date | 2024-11-21 |
| Primary Completion | 2025-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 158 participants in total. It began in 2024-11-21 with a primary completion date of 2025-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Two cross-sectional, repeated-pass, community-based studies will be carried out during the school year. The first study will be conducted from November to December. This period corresponds to the end of the rainy season and the end of the mango season, which is one of the main sources of vitamin A in the Orodara region. The second survey will be carried out 5 to 6 months (April-May of the following year) after data collection for the first study, corresponding to the mango season. The same schoolchildren recruited during the first phase of data collection (5 to 6 months earlier) will be the participants in the second study. The interest of this study is to use nuclear techniques to implement a strategy for the precise and accurate determination of Vitamin A status in order to reinforce existing Vitamin A interventions and policies.
Eligibility Criteria
Inclusion Criteria: * School children aged 7-12 years * Child's guardian or parent is willing to provide informed consent * Child's family plans to remain resident in the study areas during the study period Exclusion Criteria: * Clinical evidence of vitamin A deficiency a mis en forme : Anglais (Royaume-Uni)a mis en forme : Anglais (États-Unis)a mis en forme : Anglais (États-Unis)a mis en forme : Anglais (États-Unis) * Severe malnutrition (weight-for age Z score (WAZ) or height-for-age Z score (HAZ) \<-3 SD) * Serious illnesses including tuberculosis, symptomatic HIV infection * Child aged \<6 years or \>12 years
Contact & Investigator
Augustin N. ZEBA, PhD
PRINCIPAL INVESTIGATOR
Institut de Recherche en Sciences de la Santé
Frequently Asked Questions
Who can join the NCT06759493 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 12 Years, studying Vitamin A Deficiency. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06759493 currently recruiting?
Yes, NCT06759493 is actively recruiting participants. Contact the research team at nawidzeba@gmail.com for enrollment information.
Where is the NCT06759493 trial being conducted?
This trial is being conducted at Bobo-Dioulasso, Burkina Faso.
Who is sponsoring the NCT06759493 clinical trial?
NCT06759493 is sponsored by Institut de Recherche en Sciences de la Sante, Burkina Faso. The principal investigator is Augustin N. ZEBA, PhD at Institut de Recherche en Sciences de la Santé. The trial plans to enroll 158 participants.